To our knowledge, our findings are the first to show that higher NAT10 expression is obviously associated with LN metastasis and poor OS, demonstrating that NAT10 may act as a prognostic biomarker in HNSCC and function as an oncogenic factor in the lymphatic metastasis of HNSCC. The gene discussed is NAT10; the disease is head and neck squamous cell carcinoma.